Mexico City, Mexico — President Andrés Manuel López Obrador says next week, health authorities are expected to approve two oral drugs for treatment against covid-19.
During his Friday press conference, the president said that the Federal Commission for the Protection against Sanitary Risks (Cofepris) has already begun the authorization process after receiving the manufacturer’s file.
Mexican health authorities are expected to approve Paxlovid from Pfizer after approving Molnupiravir from the pharmaceutical company Merck Sharp and Dohme on January 7.
He says once approved, the government will acquire the drugs for the treatment of covid-19. The volume of the purchase will be decided once Cofepris issues the authorization for controlled emergency use.
The opinion on Pfizer’s paxlovid could be given by January 13. “This is good news,” he said adding that the head of Cofepris, Alejandro Svarch Pérez, will attend the morning conference on January 11, to offer more details on the matter.